# CLINICAL_TRANSLATION_CHECKPOINT.md

## Document Information

**Document:** CLINICAL_TRANSLATION_CHECKPOINT.md
**Project:** 12-Gene Gastric Cancer Signature — Part 2: Modernized Biomarker Discovery Framework
**Checkpoint:** Clinical Translation Checkpoint (end of Phase F, per IMPLEMENTATION_MASTER_PLAN.md §5/§8)
**Covers:** Module 14 (Clinical Translation), Module 15 (Clinical Outputs) — all LOCKED; completes IDS-006 in full **and the entire Coding Phase (Modules 01–15)**
**Prepared by:** Coding Agent (Claude), for Strategist AI review
**Status:** DRAFT — awaiting Strategist Review and Project Coordinator confirmation before Coding Framework Integration begins

---

## 1. Purpose

Per `IMPLEMENTATION_MASTER_PLAN.md` §8, a checkpoint verifies, across all modules in the completed phase: module completion; contract compliance; artifact integrity; lineage preservation; downstream readiness. This document assembles that evidence for Modules 14–15 (Phase F — Clinical Translation), mirroring the structure used for the Discovery, Modeling, Validation, and Interpretation Checkpoints.

**This is the final phase checkpoint of the Coding Phase.** Unlike the prior four checkpoints, which gated entry into the next Coding Phase, this checkpoint gates entry into **Coding Framework Integration** — a synthesis activity, not a new Coding Module — per the locked workflow and the Strategist's repeated guidance across the Modeling, Validation, and Interpretation Checkpoints.

This document introduces no new implementation, no new governance decision, and reinterprets nothing already LOCKED. It is a synthesis-only artifact.

---

## 2. Module Completion

| Module | Responsibility | Status | LOCK date |
|---|---|---|---|
| Module 14 | Clinical Translation (`run_clinical_translation()`, Clinical Translation Object, Clinical Translation Evidence) | LOCKED | 2026-06-29 |
| Module 15 | Clinical Outputs (`run_clinical_output()`, Clinical Output Object, Clinical Translation Package) | LOCKED | 2026-06-29 |

Both modules have a complete, LOCKED `Execution/Module_1X/` history (`Prompt.md`, `Artifacts.md`, `Execution_Log.md`, `Review.md`, `LOCK.md`), each independently Strategist-reviewed and Project-Coordinator-confirmed.

**Workflow note:** Modules 14 and 15 continued both the "Strategist-direct" review workflow (since Module 10) and the "new-files-only" packaging convention (since Module 12). Across all six modules that have now used one or both conventions (10–15), no governance or traceability gap has been observed.

**Architectural note:** per the Strategist's explicit recommendation at the Interpretation Checkpoint, Modules 14 and 15 preserved the identical Workflow → Executor → Implementation Object → Framework Artifact template with no shortcuts, **completing full architectural symmetry across all seven IDS-004/005/006 modules (09–15)**.

**Two Consistency Check clarifications** were recorded during this phase, both extending (not conflicting with) locked architecture:

1. **Module 14:** as the first module of a new domain (IDS-006), `metadata$framework_layer = "clinical_translation"` (new layer) and `metadata$artifact_role = "clinical_translation_evidence"` were introduced; default consumer `"clinical_translation_package"` (naming Module 15's responsibility directly).
2. **Module 15:** `metadata$artifact_role = "clinical_translation_package"` (sharing Module 14's `"clinical_translation"` layer); default consumer `"framework_integration"` — since Clinical Translation Package is the terminal artifact of the entire Coding Phase, with no Module 16 to name, this default points to the next governed milestone the Strategist has referenced repeatedly since the Modeling Checkpoint.

---

## 3. Contract Compliance

Both modules consume Module 02's Framework Contracts and their immediately-upstream module exactly as LOCKED — zero modifications anywhere in Phase F.

| Module | Framework artifact produced | `artifact_role` | Upstream artifact consumed (read-only) |
|---|---|---|---|
| Module 14 | Clinical Translation Evidence | `"clinical_translation_evidence"` | Interpretation Package only (Module 13) |
| Module 15 | Clinical Translation Package | `"clinical_translation_package"` | Clinical Translation Evidence only (Module 14) |

**Verification:** `contract_type` remained exactly `"artifact"` in both artifacts — confirmed by dedicated tests in each module. This is the **second new `framework_layer`** introduced since Phase D (`"clinical_translation"`, following `"interpretability"` at Phase E), confirming the layer-naming mechanism has now been exercised cleanly across **all six** IDS domain boundaries traversed in this project: `"discovery"`/`"processing"` (IDS-002) → `"modeling"` (IDS-003) → `"validation_benchmark"` (IDS-004) → `"interpretability"` (IDS-005) → `"clinical_translation"` (IDS-006). Each module strictly narrowed its consumption to exactly one upstream artifact type, continuing the one-hop consumption rule the Strategist explicitly endorsed at the Validation Checkpoint and reaffirmed at the Interpretation Checkpoint.

No new contract schema, contract type, or object model was introduced anywhere in Phase F.

---

## 4. Artifact Integrity

| Principle | Module(s) | Evidence |
|---|---|---|
| Workflow/Executor/Object/Evidence separation | 14, 15 | Each module implements the identical structural pattern established in Modules 09–13: `create_*_object()` → `run_*()` → `list(*_object, *_artifact)`. |
| Generic Implementation Principle (no real methodology) | 14, 15 | `.default_generic_translator()` and `.default_generic_output_generator()` each return only a single `structural_check` component, with `details` text explicitly disclaiming treatment-recommendation/guideline/patient-stratification/therapeutic methodology (Module 14) and treatment-recommendation/medical-advice/guideline/patient-management methodology (Module 15) — verified directly in tests. |
| Callback extensibility | 14, 15 | `translator`/`output_generator` parameters, defaulting to `NULL` → internal generic default, complete the now **seven-instance** callback pattern (`trainer`, `validator`, `benchmarker`, `selector`, `interpreter`, `integrator`, `translator`/`output_generator`) spanning Modules 07 and 09–15. |
| Read-only upstream consumption | 14, 15 | Verified directly: Interpretation Package unchanged after Module 14; Clinical Translation Evidence unchanged after Module 15 — via `identical()` against independent copies/originals. |
| Multiple independent components (no opaque collapse) | 14, 15 | Each module's workflow function tested with 3 named components, returned intact and distinguishable. |
| Forbidden-content guards | 14, 15 | Module 14's Clinical Translation Evidence rejects `treatment_recommendation`, `clinical_guideline_reasoning`, `clinician_facing_interpretation`, `patient_recommendation`, `clinical_decision_support`; Module 15's Clinical Translation Package rejects `treatment_recommendation`, `medical_advice`, `physician_decision_support`, `guideline_interpretation`, `patient_management`, `publication_ready_discussion` — both at construction and validation time, tested explicitly. |
| Anti-duplication via direct reuse | 14, 15 | Module 14 calls Module 13's exported `validate_interpretation_package()` directly; Module 15 calls Module 14's exported `validate_clinical_translation_evidence()` directly — neither reimplements upstream validation logic. |

---

## 5. Lineage Preservation — End-to-End Trace, Module 14 → 15 (and the Complete Coding Phase)

The following trace completes the chain begun at the Discovery Checkpoint, now spanning the **entire Coding Phase**:

```
(...continued from Interpretation Checkpoint: interpretation_package,
 embedding evidence_integration_object, produced by Module 13...)
        |
        v
Module 14                                          Module 15
----------                                          ----------
create_clinical_translation_object(interpretation_package)
        |
        v
[clinical_translation_object]
        |
run_clinical_translation(clinical_translation_object)
        |
        v
[clinical_translation_object (updated)] -> create_clinical_translation_evidence()
        |
        v
[clinical_translation_evidence: artifact_contract,
 framework_layer = "clinical_translation",
 artifact_role = "clinical_translation_evidence",
 embeds clinical_translation_object]
        |
        +-----------------------------------------> create_clinical_output_object(clinical_translation_evidence)
                                                              |
                                                              v
                                                      [clinical_output_object]
                                                              |
                                                      run_clinical_output(clinical_output_object)
                                                              |
                                                              v
                                                      [clinical_output_object (updated)] -> create_clinical_translation_package()
                                                              |
                                                              v
                                                      [clinical_translation_package: artifact_contract,
                                                       framework_layer = "clinical_translation",
                                                       artifact_role = "clinical_translation_package",
                                                       consumer = "framework_integration",
                                                       embeds clinical_output_object]
                                                              |
                                                              v
                                              *** FINAL ARTIFACT OF THE ENTIRE CODING PHASE ***
                                                              |
                                                              v
                                              ready for Coding Framework Integration
```

**Key lineage guarantees confirmed by this trace:**
- The original Module 04 Discovery artifact (`metadata$framework_layer = "processing"`) remains traceable, byte-for-byte unchanged, through the **complete 13-module chain**: `model_contract` → `model_object` → `training_object` → `model_candidate`/`modeling_evidence` → `validation_object` → `validation_evidence` → `benchmark_object` → `benchmark_evidence` → `candidate_selection_object` → `validated_candidate` → `interpretation_object` → `interpretation_evidence` → `evidence_integration_object` → `interpretation_package` → `clinical_translation_object` → **`clinical_translation_evidence`** → `clinical_output_object` → **`clinical_translation_package`**.
- This is confirmed directly by `test-clinical-output.R::"create_clinical_translation_package integrates end-to-end across the complete Coding Phase (Modules 06-15)"` — a single automated test asserting `identical()` between the original Discovery artifact and the one reachable by drilling through Clinical Translation Package's full embedded lineage, spanning all of Modules 06 through 15.
- No step in Phase F duplicates upstream validation/contract logic (Section 4).
- One-hop consumption held throughout the entire Coding Phase, not just Phase F: every Workflow/Executor module from Module 09 through Module 15 consumed exactly one immediately-upstream artifact type, with all earlier artifacts remaining reachable only through preserved embedding, never through direct cross-module reference.

---

## 6. API Stability Inventory

| Module | Exported function | Signature | Returns |
|---|---|---|---|
| 14 | `create_clinical_translation_object()` | `(interpretation_package, metadata = list())` | `clinical_translation_object` |
| 14 | `validate_clinical_translation_object()` | `(x)` | invisible `TRUE` or error |
| 14 | `run_clinical_translation()` | `(clinical_translation_object, translator = NULL, ...)` | `list(clinical_translation_object, clinical_translation_evidence)` |
| 14 | `create_clinical_translation_evidence()` | `(clinical_translation_object, producer = NULL, consumer = "clinical_translation_package", metadata = list())` | `clinical_translation_evidence` |
| 14 | `validate_clinical_translation_evidence()` | `(x)` | invisible `TRUE` or error |
| 14 | `print.clinical_translation_object()` / `print.clinical_translation_evidence()` | S3 only | invisible `x` |
| 15 | `create_clinical_output_object()` | `(clinical_translation_evidence, metadata = list())` | `clinical_output_object` |
| 15 | `validate_clinical_output_object()` | `(x)` | invisible `TRUE` or error |
| 15 | `run_clinical_output()` | `(clinical_output_object, output_generator = NULL, ...)` | `list(clinical_output_object, clinical_translation_package)` |
| 15 | `create_clinical_translation_package()` | `(clinical_output_object, producer = NULL, consumer = "framework_integration", metadata = list())` | `clinical_translation_package` |
| 15 | `validate_clinical_translation_package()` | `(x)` | invisible `TRUE` or error |
| 15 | `print.clinical_output_object()` / `print.clinical_translation_package()` | S3 only | invisible `x` |

**Total: 14 exported public symbols across the Clinical Translation domain (Modules 14–15)** — 10 via `export()`, 4 S3 print methods via `S3method()` registration only. Zero renames, zero semantic changes, zero breaking changes since each function's respective LOCK.

**The framework now exposes 77 stable public API symbols at the completion of the entire Coding Phase** (63 from Phases B–E, per the Interpretation Checkpoint, + 14 from Phase F).

---

## 7. Test Coverage Summary

| Test file | Module | Assertions (PASS) |
|---|---|---|
| `test-clinical-translation.R` | 14 | 62 |
| `test-clinical-output.R` | 15 | 65 |
| **Clinical Translation domain subtotal** | | **127** |
| **Full package suite (Modules 01–15 combined — the entire Coding Phase)** | — | **781** |

All 781 assertions pass with `[ FAIL 0 | WARN 0 | SKIP 0 ]`, confirmed at each module's local execution and re-confirmed cumulatively at every subsequent module, all the way through Module 15.

`devtools::check()` at every module across the entire Coding Phase: **0 errors, 0 warnings**, 1 note (system-clock-related, accepted as expected at this project stage — consistent across Modules 02–15, 14 consecutive modules).

No treatment recommendation, medical advice, physician decision support, guideline interpretation, patient management, or publication-ready discussion is tested anywhere in the Clinical Translation domain, consistent with the Generic Implementation Principle carried through the entire Coding Phase.

No test-fixture or implementation issues required correction in this phase.

---

## 8. Downstream Compatibility

The Clinical Translation domain's output, as implemented by Module 15, is the **terminal artifact of the entire Coding Phase**:

- Exactly one Clinical Translation Package is produced per Clinical Output Object, a stable `artifact_contract`-based Framework artifact (`contract_type == "artifact"`, `metadata$artifact_role == "clinical_translation_package"`, `consumer == "framework_integration"` by default).
- Clinical Translation Package structurally forbids treatment recommendation, medical advice, physician decision support, guideline interpretation, patient management, and publication-ready discussion — meaning any future, separate clinical/publication-facing work (explicitly outside this Coding Phase) is the first activity authorized to introduce such content, with a clean, unambiguous starting boundary — mirroring the same pattern observed at every prior domain transition (Discovery→Modeling, Modeling→Validation, Validation→Interpretability, Interpretability→Clinical Translation).
- The `trainer`/`validator`/`benchmarker`/`selector`/`interpreter`/`integrator`/`translator`/`output_generator` callback pattern (Modules 07, 09–15) is now complete across all seven Workflow/Executor modules of the Coding Phase, confirmed by the Strategist as the official Coding Phase execution pattern.
- No real ML/statistical/biological/clinical methodology has been "locked in" anywhere in Modules 06–15 — the entire Modeling, Validation & Benchmark, Interpretability, and Clinical Translation domains remain generic scaffolding, fully ready for the project's actual methodology to be introduced via callbacks in future, additive work, without requiring rework of any LOCKED module.
- The complete `metadata$framework_layer` taxonomy (six values across IDS-002–IDS-006) and the complete `metadata$artifact_role` taxonomy (nine values: `model_candidate`, `modeling_evidence`, `validation_evidence`, `benchmark_evidence`, `validated_candidate`, `interpretation_evidence`, `interpretation_package`, `clinical_translation_evidence`, `clinical_translation_package`) are now both fully instantiated and ready for synthesis at Coding Framework Integration, per the Strategist's guidance at the Modeling and Validation Checkpoints (not to be formalized into Governance until that synthesis step).

---

## 9. Open Items / Carried-Forward Notes

- **Workflow changes absorbed cleanly across the entire back half of the Coding Phase:** the "Strategist-direct" review workflow (since Module 10) and the "new-files-only" packaging convention (since Module 12) introduced no governance or execution-history gaps across six consecutive modules (10–15).
- **Carried over from prior Checkpoints:** IDS-002's Discovery Candidate/Evidence taxonomy remains uninstantiated as a distinct pair (Module 04 produces one generic artifact) — unrelated to, and unaffected by, IDS-003/004/005/006's now-complete artifact taxonomies.
- **Carried over from Module 09:** a future (non-blocking) documentation enhancement may explicitly document `trained_model` as an intentionally opaque implementation object — still deferred, not required.
- **Carried over from every prior Checkpoint:** the `metadata$framework_layer` / `metadata$artifact_role` taxonomy should be synthesized into Framework documentation at Coding Framework Integration — **this is now actionable**, since the Coding Phase that was the precondition for that synthesis is complete.
- **No new open items were raised in Module 14 or 15's reviews** beyond standard "no revisions required."

---

## 10. Checkpoint Self-Assessment (Coding Agent, pre-Strategist)

- [x] Module completion — Modules 14, 15 both LOCKED with complete execution history; IDS-006 fully complete; **the entire Coding Phase (Modules 01–15) is complete.**
- [x] Contract compliance — Module 02 contracts and each module's immediately-upstream artifact used unmodified throughout; second new `framework_layer` since Phase D introduced cleanly, completing the six-domain taxonomy.
- [x] Artifact integrity — Workflow/Executor/Object/Evidence separation, generic-only defaults, callback extensibility, read-only consumption, multiple-component support, and forbidden-content guards all verified in tests across both modules.
- [x] Lineage preservation — End-to-end trace (Section 5), continuous from Module 04 through Module 15 (13 modules deep, the complete Coding Phase chain), confirmed by a single comprehensive automated test.
- [x] Downstream readiness — Clinical Translation Package is the stable, terminal artifact of the Coding Phase, ready for Coding Framework Integration; 14 new public APIs frozen with zero breaking changes; 77 total stable public API symbols across the entire Coding Phase.

This self-assessment does not substitute for Strategist Review. Per `IMPLEMENTATION_MASTER_PLAN.md` §8, this checkpoint gates entry into Coding Framework Integration.

---

## 11. Requested Strategist Actions

1. Review Sections 2–9 above against the underlying `Execution/Module_14/`, `Module_15/` records for accuracy.
2. Confirm or challenge the Section 10 self-assessment against each of the five checkpoint criteria.
3. Confirm that the two Consistency Check clarifications across Modules 14–15 remain architecturally sound, in particular the introduction of the second new `metadata$framework_layer` value and the choice of `"framework_integration"` as Module 15's default consumer (there being no Module 16).
4. Confirm the combined "Strategist-direct review" + "new-files-only packaging" workflow has not introduced any cumulative drift across the full six-module span (Modules 10–15) it has now covered.
5. Issue an explicit **Clinical Translation Checkpoint** verdict: **PASS** (proceed to Coding Framework Integration) or **REVISION REQUIRED**.
6. Given that this is the **final phase checkpoint** of the Coding Phase, provide any closing guidance on what Coding Framework Integration should synthesize — in particular, whether the complete `framework_layer` (6 values) and `artifact_role` (9 values) taxonomies, the seven-instance callback pattern, and the Workflow/Executor/Object/Evidence architecture (now exercised identically across Modules 09–15) are ready to be formalized into Framework documentation, as has been deferred at every prior checkpoint pending exactly this completion.

---

End of CLINICAL_TRANSLATION_CHECKPOINT.md (draft, for Strategist Review).

---
---

# CLINICAL_TRANSLATION_CHECKPOINT_REVIEW.md

**Checkpoint:** Clinical Translation Checkpoint (Phase F Integration)
**Reviewer:** Strategist AI (ChatGPT)
**Status:** PASS

---

## Governance Compliance

**PASS.** Phase F fully complies with Governance v4.6.

## IDS Compliance

**PASS.** IDS-006 is fully implemented.

## Architecture Compliance

**PASS.** Workflow → Executor → Implementation Object → Framework Artifact remains unchanged. Modules 09–15 now form one fully consistent architectural family.

## Contract Compliance

**PASS.** Framework Contracts remain stable. No contract drift detected.

## Runtime Verification

**PASS.** Local execution, package tests, package checks, and runtime demonstrations all completed successfully.

## Lineage Preservation

**PASS.** Complete end-to-end lineage from Discovery through Clinical Translation Package is preserved.

## Generic Implementation Principle

**PASS.** No scientific or clinical methodology has been embedded. Default implementations remain structural only.

## Callback Architecture

**PASS.** The callback execution pattern has been successfully completed across the Coding Phase.

## Downstream Readiness

**PASS.** Clinical Translation Package is ready for Coding Framework Integration.

---

## Required Revisions

**None.**

---

## Strategist Recommendation

**Approve the Clinical Translation Checkpoint.**

**Proceed to Coding Framework Integration.**
